These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 1958084)
21. When do bisphosphonates make the most sense? Winzenberg T; Jones G J Fam Pract; 2011 Jan; 60(1):18-28. PubMed ID: 21209974 [No Abstract] [Full Text] [Related]
22. Conference report--scientific and clinical developments in osteoporosis. Lindsay R Medscape Womens Health; 1999 Nov; 4(6):1. PubMed ID: 10629069 [No Abstract] [Full Text] [Related]
23. Drugs for prevention and treatment of postmenopausal osteoporosis. Med Lett Drugs Ther; 2000 Oct; 42(1090):97-100. PubMed ID: 11035622 [No Abstract] [Full Text] [Related]
24. Critical drug appraisal: etidronate intermittent cyclic therapy for postmenopausal osteoporosis. Miller PD Br J Clin Pract; 1996; 50(1):23-31. PubMed ID: 8729598 [TBL] [Abstract][Full Text] [Related]
26. Strategies for the prevention and treatment of osteoporosis during early postmenopause. Delaney MF Am J Obstet Gynecol; 2006 Feb; 194(2 Suppl):S12-23. PubMed ID: 16448872 [TBL] [Abstract][Full Text] [Related]
27. Treatment of postmenopausal osteoporosis with etidronate. Heyneman CA Ann Pharmacother; 1993 Oct; 27(10):1200-1. PubMed ID: 8251688 [No Abstract] [Full Text] [Related]
28. Therapeutic options: an evidence-based approach to prevention and treatment of osteoporosis. Miller E Int J Fertil Womens Med; 2003; 48(3):122-6; discussion 137-8. PubMed ID: 12839143 [TBL] [Abstract][Full Text] [Related]
35. [Comparative effects of sodium fluoride and hormonal replacement therapy on bone metabolism in osteoporotic women with high fracture risk. Results of monitoring for 2 years]. Pouillès JM; Trémollières F; Ribot C Rev Rhum Mal Osteoartic; 1992 Feb; 59(2):103-13. PubMed ID: 1604221 [TBL] [Abstract][Full Text] [Related]